Wnt pathway activation in mesothelioma: Evidence of dishevelled overexpression and transcriptional activity of β-catenin

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4547-4551

  Uematsu, Kazutsugu ^a,c   Kanazawa, Satoshi ^b   You, Liang ^a   He, Biao ^a   Xu, Zhidong ^a   Li, Kai ^a   Peterlin, B Matija ^b   McCormick, Frank ^a   Jablons, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; T CELL FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DELETION MUTANT; DISHEVELLED GENE; DV1 GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MESOTHELIOMA; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE; ONCOGENE C MYC; PATHOGENESIS; PDZ DV1 GENE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BETA CATENIN; CELL DIVISION; CYTOPLASM; CYTOSKELETAL PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESOTHELIOMA; MICE; MICE, NUDE; PHOSPHOPROTEINS; PLEURAL NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0043092191     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bueno, R. Mesothelioma clinical presentation. Chest, 116: 444S-445S, 1999.
2. Testa, J. R., and Giordano, A. SV40 and cell cycle perturbations in malignant mesothelioma. Semin. Cancer Biol., 11: 31-38, 2001.
3. Butchart, E. G. Contemporary management of malignant pleural mesothelioma. Oncologist, 4: 488-500, 1999.
4. Matsuzawa, S. I., and Reed, J. C. Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol. Cell, 7: 915-926, 2001.
5. Liu, J., Stevens, J., Rote, C. A., Yost, H. J., Hu, Y., Neufeld, K. L., White, R. L., and Matsunami, N. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell, 7: 927-936, 2001.
6. Morin, P. J. β-Catenin signaling and cancer. Bioessays, 21: 1021-1030, 1999.
7. Sokol, S. Y. Analysis of Dishevelled signalling pathways during Xenopus development. Curr. Biol., 6: 1456-1467, 1996.
8. Yanagawa, S., van Leeuwen, F., Wodarz, A., Klingensmith, J., and Nusse, R. The dishevelled protein is modified by wingless signaling in Drosophila. Genes Dev., 9: 1087-1097, 1995.
9. Steitz, S. A., Tsang, M., and Sussman, D. J. Wnt-mediated relocalization of dishevelled proteins. In Vitro Cell Dev. Biol. Anim., 32: 441-445, 1996.
10. Krasnow, R. E., Wong, L. L., and Adler, P. N. Dishevelled is a component of the frizzled signaling pathway in Drosophila. Development (Camb.), 121: 4095-4102, 1995.
11. Rothbacher, U., Laurent, M. N., Blitz, I. L., Watabe, T., Marsh, J. L., and Cho, K. W. Functional conservation of the Wnt signaling pathway revealed by ectopic expression of Drosophila dishevelled in Xenopus. Dev. Biol., 170: 717-721, 1995.
12. Wagner, U., Brownlees, J., Irving, N. G., Lucas, F. R., Salinas, P. C., and Miller, C. C. Overexpression of the mouse dishevelled-1 protein inhibits GSK-3β-mediated phosphorylation of tau in transfected mammalian cells. FEBS Lett., 411: 369-372, 1997.
13. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16: 3797-3804, 1997.
14. Orford, K., Crockett, C., Jensen, J. P., Weissman, A. M., and Byers, S. W. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem., 272: 24735-24738, 1997.
15. Cox, R. T., and Peifer, M. Wingless signaling: the inconvenient complexities of life. Curr. Biol., 8: R140-R144, 1998.
16. Willert, K., and Nusse, R. β-Catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev., 8: 95-102, 1998.
17. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998.
18. Tetsu, O., and McCormick, F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.
19. Shu, S. Y., and Rosenberg, S. A. Adoptive immunotherapy of newly induced murine sarcomas. Cancer Res., 45: 1657-1662, 1985.
20. Lechner, J. F., Tokiwa, T., LaVeck, M., Benedict, W. F., Banks-Schlegel, S., Yeager, H., Jr., Banerjee, A., and Harris, C. C. Asbestos-associated chromosomal changes in human mesothelial cells. Proc. Natl. Acad. Sci. USA, 82: 3884-3888, 1985.
21. Shimizu, H., Julius, M. A., Giarre, M., Zheng, Z., Brown, A. M., and Kitajewski, J. Transformation by Wnt family proteins correlates with regulation of β-catenin. Cell Growth Differ., 8: 1349-1358, 1997.
22. Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science (Wash. DC), 275: 1784-1787, 1997.
23. Polakis, P. Wnt signaling and cancer. Genes Dev., 14: 1837-1851, 2000.
24. Zeng, L., Fagotto, F., Zhang, T., Hsu, W., Vasicek, T. J., Perry, W. L., III, Lee, J. J., Tilghman, S. M., Gumbiner, B. M., and Costantini, F. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell, 90: 181-192, 1997.
25. Ponting, C. P., Phillips, C., Davies, K. E., and Blake, D. J. PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays, 19: 469-479, 1997.
26. Ponting, C. P., and Bork, P. Pleckstrin's repeat performance: a novel domain in G-protein signaling? Trends Biochem. Sci., 21: 245-246, 1996.
27. Li, L., Yuan, H., Xie, W., Mao, J., Caruso, A. M., McMahon, A., Sussman, D. J., and Wu, D. Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J. Biol. Chem., 274: 129-134, 1999.
28. Hino, S., Kishida, S., Michiue, T., Fukui, A., Sakamoto, I., Takada, S., Asashima, M., and Kikuchi, A. Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. Mol. Cell. Biol., 21: 330-342, 2001.
29. Ramael, M., Van den Bossche, J., Buysse, C., Deblier, I., Segers, K., and Van Marck, E. Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura. Histol. Histopathol., 10: 639-643, 1995.
30. Howe, L. R., Subbaramaiah, K., Chung, W. J., Dannenberg, A. J., and Brown, A. M. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res., 59: 1572-1577, 1999.
31. Haertel-Wiesmann, M., Liang, Y., Fantl, W. J., and Williams, L. T. Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J. Biol. Chem., 275: 32046-32051, 2000.
32. Edwards, J. G., Faux, S. P., Plummer, S. M., Abrams, K. R., Walker, R. A., Waller, D. A., and O'Byrne, K. J. Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma. Clin. Cancer Res., 8: 1857-1862, 2002.